Details for New Drug Application (NDA): 064210
✉ Email this page to a colleague
NDA 064210 describes STREPTOMYCIN SULFATE, which is a drug marketed by Copanos, Lilly, Pfizer, and Xgen Pharms, and is included in six NDAs. It is available from one supplier. Additional details are available on the STREPTOMYCIN SULFATE profile page.
The generic ingredient in STREPTOMYCIN SULFATE is streptomycin sulfate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the streptomycin sulfate profile page.
The generic ingredient in STREPTOMYCIN SULFATE is streptomycin sulfate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the streptomycin sulfate profile page.
Summary for 064210
| Tradename: | STREPTOMYCIN SULFATE |
| Applicant: | Xgen Pharms |
| Ingredient: | streptomycin sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 064210
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| STREPTOMYCIN SULFATE | streptomycin sulfate | INJECTABLE;INJECTION | 064210 | ANDA | XGen Pharmaceuticals DJB, Inc. | 39822-0706 | 39822-0706-2 | 10 VIAL in 1 BOX (39822-0706-2) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0706-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Jun 30, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
